Several rare inherited disorders have provided valuable experiments of nature highlighting specific biological processes of particular importance to the survival or function of midbrain dopamine neurons. In both humans and mice, deficiency of hypoxanthine-guanine phosphoribosyl transferase (HPRT) is associated with profound loss of striatal dopamine, with relative preservation of other neurotransmitters. In the current studies of knockout mice, no morphological signs of abnormal development or degeneration were found in an exhaustive battery that included stereological and morphometric measures of midbrain dopamine neurons, electron microscopic studies of striatal axons and terminals, and stains for degeneration or gliosis. A novel culture model involving HPRT-deficient dopaminergic neurons also exhibited significant loss of dopamine without a morphological correlate. These results suggest that dopamine loss in HPRT deficiency has a biochemical rather than anatomical basis and imply that purine recycling to be a biochemical process of particular importance to the function of dopaminergic neurons.
Introduction
Parkinson's disease is associated with degeneration of nigrostriatal dopamine neurons. The mechanisms responsible for selective loss of these neurons are not yet understood. Available evidence suggests that these neurons are especially sensitive to certain biochemical processes such as mitochondrial dysfunction, oxidative stress, and proteasome dysfunction.
Several rare monogenic forms of parkinsonism provide important insights into biochemical processes particularly important for midbrain dopamine neurons (Cookson, 2005; Moore et al., 2005; Zeevalk et al., 2005; About-Sleiman et al., 2006) . The importance of mitochondrial dysfunction is highlighted by parkinsonism resulting from mutations affecting the mitochondrial proteins DJ-1, PINK1 and HTRA2. Studies of DJ-1 and PINK1 similarly have strengthened the idea that dopamine neurons are especially sensitive to oxidative stress. A role for handling of misfolded proteins is emphasized by parkinsonism associated with familial defects of protein folding related to mutations of α-synuclein and by defects involving the handling of misfolded proteins by the proteasome, such as Parkin and UCHL1. Although these monogenic forms of parkinsonism are rare, they provide valuable experiments of nature pointing to specific biological processes of particular relevance to dopamine neurons (Antonarakis and Beckmann, 2006) .
Another monogenic disorder associated with selective dysfunction of midbrain dopamine neurons is Lesch-Nyhan disease (Visser et al., 2000) . Because dopaminergic systems are affected early in childhood, these patients present with dystonia rather than parkinsonism (Jinnah et al., 2006) . The disease is caused by the deficiency of hypoxanthine-guanine phosphoribosyl transferase (HPRT), an enzyme of the purine salvage pathway (Jinnah et al., 2000) . The most consistent neurochemical abnormality in the brains of these individuals is 70-90% loss of dopamine in the basal ganglia (Lloyd et al., 1981; Saito et al., 1999 (Ernst et al., 1996; Wong et al., 1996) .
Significant loss of dopamine also occurs in HPRT-deficient (HPRT − ) knockout mice. These mice have been useful for documenting two important aspects of the dopamine defect. The first is that loss of dopamine is neuroanatomically selective. The striatum is affected but other regions are not (Jinnah et al., 1992b; Jinnah et al., 1994) . The second is that loss of dopamine is neurochemically selective. There is no accompanying loss of norepinephrine, serotonin, or GABA (Jinnah et al., 1994 (Jinnah et al., , 1999 Hyland et al., 2004) . The selective neuroanatomical and neurochemical consequences of HPRT deficiency suggest that purine recycling is another biological process of particular importance to midbrain dopamine neurons. The reasons for the loss of striatal dopamine in the HPRT − brain are not fully understood. They are hypothesized to result from failed development or early degeneration of dopamine neurons or their axons (Lloyd et al., 1981; Ernst et al., 1996; Wong et al., 1996 
